Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for ESTEVE PHARMACEUTICALS, LLC · Pharmaceutical manufacturer of highly specialized medicines in areas of a high unmet need.

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$20,000
What the client paid this registrant for the period.

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Health Issues

Issues related to reimbursement and coverage for certain drugs.

Medicare/Medicaid

Issues related to reimbursement and coverage for certain drugs.

 Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

  • ESTEVE PHARMACEUTICALS, S.A.
    Spain · Barcelona · owns 100% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem